These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 25496981

  • 1. First-line therapy in atypical hemolytic uremic syndrome: consideration on infants with a poor prognosis.
    Szarvas N, Szilágyi Á, Tasic V, Nushi-Stavileci V, Sofijanova A, Gucev Z, Szabó M, Szabó A, Szeifert L, Reusz G, Rusai K, Arbeiter K, Müller T, Prohászka Z.
    Ital J Pediatr; 2014 Dec 11; 40():101. PubMed ID: 25496981
    [Abstract] [Full Text] [Related]

  • 2.
    Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Noris M, Bresin E, Mele C, Remuzzi G.
    ; 1993 Dec 11. PubMed ID: 20301541
    [Abstract] [Full Text] [Related]

  • 3. [Atypical HUS caused by complement-related abnormalities].
    Yoshida Y, Matsumoto M.
    Rinsho Ketsueki; 2015 Feb 11; 56(2):185-93. PubMed ID: 25765799
    [Abstract] [Full Text] [Related]

  • 4. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.
    Krishnappa V, Gupta M, Elrifai M, Moftakhar B, Ensley MJ, Vachharajani TJ, Sethi SK, Raina R.
    Ther Apher Dial; 2018 Apr 11; 22(2):178-188. PubMed ID: 29250893
    [Abstract] [Full Text] [Related]

  • 5. The role of complement in Streptococcus pneumoniae-associated haemolytic uraemic syndrome.
    Szilágyi A, Kiss N, Bereczki C, Tálosi G, Rácz K, Túri S, Györke Z, Simon E, Horváth E, Kelen K, Reusz GS, Szabó AJ, Tulassay T, Prohászka Z.
    Nephrol Dial Transplant; 2013 Sep 11; 28(9):2237-45. PubMed ID: 23787556
    [Abstract] [Full Text] [Related]

  • 6. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V, Fakhouri F, Roumenina L, Dragon-Durey MA, Loirat C.
    Rev Med Interne; 2011 Apr 11; 32(4):232-40. PubMed ID: 21376430
    [Abstract] [Full Text] [Related]

  • 7. Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti-Factor H IgAλ Antibody.
    Rigothier C, Delmas Y, Roumenina LT, Contin-Bordes C, Lepreux S, Bridoux F, Goujon JM, Bachelet T, Touchard G, Frémeaux-Bacchi V, Combe C.
    Am J Kidney Dis; 2015 Aug 11; 66(2):331-6. PubMed ID: 26015278
    [Abstract] [Full Text] [Related]

  • 8. Hemolytic uremic syndrome with dual caution in an infant: cobalamin C defect and complement dysregulation successfully treated with eculizumab.
    Barlas UK, Kıhtır HS, Goknar N, Ersoy M, Akcay N, Sevketoglu E.
    Pediatr Nephrol; 2018 Jun 11; 33(6):1093-1096. PubMed ID: 29558000
    [Abstract] [Full Text] [Related]

  • 9. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
    Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa L, Espinosa M, Grinyó JM, Macía M, Mendizábal S, Praga M, Román E, Torra R, Valdés F, Vilalta R, Rodríguez de Córdoba S.
    Nefrologia; 2015 Jun 11; 35(5):421-47. PubMed ID: 26456110
    [Abstract] [Full Text] [Related]

  • 10. Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea.
    Cheong HI, Jo SK, Yoon SS, Cho H, Kim JS, Kim YO, Koo JR, Park Y, Park YS, Shin JI, Yoo KH, Oh D.
    J Korean Med Sci; 2016 Oct 11; 31(10):1516-28. PubMed ID: 27550478
    [Abstract] [Full Text] [Related]

  • 11. An international consensus approach to the management of atypical hemolytic uremic syndrome in children.
    Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, Coppo R, Emma F, Johnson S, Karpman D, Landau D, Langman CB, Lapeyraque AL, Licht C, Nester C, Pecoraro C, Riedl M, van de Kar NC, Van de Walle J, Vivarelli M, Frémeaux-Bacchi V, HUS International.
    Pediatr Nephrol; 2016 Jan 11; 31(1):15-39. PubMed ID: 25859752
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of eculizumab in adult patients with atypical hemolytic uremic syndrome: A single center experience from Turkey.
    Gediz F, Payzin BK, Ecemis S, Güler N, Yilmaz AF, Topcugil F, Berdeli A.
    Transfus Apher Sci; 2016 Dec 11; 55(3):357-362. PubMed ID: 27742267
    [Abstract] [Full Text] [Related]

  • 13. Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome.
    Westra D, Volokhina EB, van der Molen RG, van der Velden TJ, Jeronimus-Klaasen A, Goertz J, Gracchi V, Dorresteijn EM, Bouts AH, Keijzer-Veen MG, van Wijk JA, Bakker JA, Roos A, van den Heuvel LP, van de Kar NC.
    Pediatr Nephrol; 2017 Feb 11; 32(2):297-309. PubMed ID: 27718086
    [Abstract] [Full Text] [Related]

  • 14. Innovative therapeutic approach: sequential treatment with plasma exchange and eculizumab in a pregnant woman affected by atypical hemolytic-uremic syndrome.
    Mussoni MP, Veneziano FA, Boetti L, Tassi C, Calisesi C, Nucci S, Rigotti A, Panzini I, Ardissino G.
    Transfus Apher Sci; 2014 Oct 11; 51(2):134-6. PubMed ID: 25294113
    [Abstract] [Full Text] [Related]

  • 15. An effective treatment of atypical hemolytic uremic syndrome with plasma exchange and eculizumab: A case report.
    Sengul Samanci N, Ayer M, Ergen A, Ozturk S.
    Transfus Apher Sci; 2015 Jun 11; 52(3):314-6. PubMed ID: 25634788
    [Abstract] [Full Text] [Related]

  • 16. Glucose-6-Phosphate Dehydrogenase Deficiency Mimicking Atypical Hemolytic Uremic Syndrome.
    Walsh PR, Johnson S, Brocklebank V, Salvatore J, Christian M, Kavanagh D.
    Am J Kidney Dis; 2018 Feb 11; 71(2):287-290. PubMed ID: 29248304
    [Abstract] [Full Text] [Related]

  • 17. Complement factor H-antibody-associated hemolytic uremic syndrome: pathogenesis, clinical presentation, and treatment.
    Hofer J, Giner T, Józsi M.
    Semin Thromb Hemost; 2014 Jun 11; 40(4):431-43. PubMed ID: 24799303
    [Abstract] [Full Text] [Related]

  • 18. Atypical hemolytic uremic syndrome.
    Loirat C, Frémeaux-Bacchi V.
    Orphanet J Rare Dis; 2011 Sep 08; 6():60. PubMed ID: 21902819
    [Abstract] [Full Text] [Related]

  • 19. [Pathophysiology of atypical hemolytic uremic syndrome. Ten years of progress, from laboratory to patient].
    Frémeaux-Bacchi V.
    Biol Aujourdhui; 2013 Sep 08; 207(4):231-40. PubMed ID: 24594571
    [Abstract] [Full Text] [Related]

  • 20. Liver transplantation for aHUS: still needed in the eculizumab era?
    Coppo R, Bonaudo R, Peruzzi RL, Amore A, Brunati A, Romagnoli R, Salizzoni M, Galbusera M, Gotti E, Daina E, Noris M, Remuzzi G.
    Pediatr Nephrol; 2016 May 08; 31(5):759-68. PubMed ID: 26604087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.